Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma.

Zhang, Xi; Zhang, Mingcong; Song, Lebin; Wang, Shuai; Wei, Xiyi; Shao, Wenchuan; Song, Ninghong

Zhang, Xi; Zhang, Mingcong; Song, Lebin; Wang, Shuai; Wei, Xiyi; Shao, Wenchuan; Song, Ninghong.

Afiliação

Zhang X; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Zhang M; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Song L; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Wang S; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Wei X; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Shao W; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Song N; The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. songninghong_urol@163.com.

Sci Rep ; 13(1): 20266, 2023 11 20.

Article em En | MEDLINE | ID: mdl-37985807

Assuntos

Carcinoma de Células Renais; Carcinoma; Neoplasias Renais; Humanos; Carcinoma de Células Renais/genética; Carcinoma de Células Renais/terapia; Proteômica; Morte Celular; Prognóstico; Imunoterapia; Neoplasias Renais/genética; Neoplasias Renais/terapia; Microambiente Tumoral/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma / Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google